Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02988687 · ClinicalTrials.gov registry record
Metabolic and QOL Effects of GH Treatment in Patients With TBI and AGHD
A clinical trial, sponsored by Garcia, Jose M., MD, PhD.
- Completed
- Registry status
- 7
- Enrollment target
NCT02988687 is a clinical trial that has completed, run by Garcia, Jose M., MD, PhD. The registered enrollment target is 7 participants.
The verdict
NCT02988687 has completed, sponsored by Garcia, Jose M., MD, PhD.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
This PILOT, NON-INTERVENTIONAL STUDY will follow patients about to start rhGH for a period of six months and collect valuable pilot data to evaluate feasibility of a larger study and treatment tolerability and compliance. The effect of rhGH on cognitive function, depression, fatigue, sleep quality, and QOL will also be collected. This exploratory study will also provide important information about recruitment and AGHD screening procedures in military settings.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-11 |
| Est. Completion | 2022-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02988687
The ClinicalTrials.gov registry entry for NCT02988687 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Garcia, Jose M., MD, PhD, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02988687 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02988687 about?
NCT02988687 is a clinical study titled "Metabolic and QOL Effects of GH Treatment in Patients With TBI and AGHD". This PILOT, NON-INTERVENTIONAL STUDY will follow patients about to start rhGH for a period of six months and collect valuable pilot data to evaluate feasibility of a larger study and treatment tolerability and compliance. The effect of rhGH on cognitive function, depression, fatigue, sleep quality, ...
What is the current status of trial NCT02988687?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2016-11. Estimated completion is 2022-10.
Who is sponsoring clinical trial NCT02988687?
This trial is sponsored by Garcia, Jose M., MD, PhD, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.